GRObeta

BT-AP10289

Rabbit

IgG

100ul,50ul,20ul

Polyclonal

Synthesized peptide derived from human GROβ

The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen.

1 mg/ml

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

-20°C for 1 year

Produced by activated monocytes and neutrophils and expressed at sites of inflammation. Hematoregulatory chemokine| which| in vitro| suppresses hematopoietic progenitor cell proliferation. GRO-beta(5-73) shows a highly enhanced hematopoietic activity.|online information:CXCL2 entry|pharmaceutical:GRO-beta(5-73) is available under the name Garnocestim as immunomodulator. It is used prior to hematopoietic transplantation for peripheral blood stem cell mobilization and reduction of incidence| duration| and/or severity of chemotherapy induced cytopenias.|PTM:The N-terminal processed form GRO-beta(5-73) is produced by proteolytic cleavage after secretion from bone marrow stromal cells.|Belongs to the intercrine alpha (chemokine CxC) family.|

Human: P19875; Mouse: P10889; Rat: P30348;

11770

Human: 2920; Mouse: 20310; Rat: 114105

GROβ; C-X-C motif chemokine 2; Growth-regulated protein beta; Gro-beta; Macrophage inflammatory protein 2-alpha; MIP2-alpha; GRO-beta;5-73; GRO-beta-T; Hematopoietic synergistic factor; HSF; SB-251353;

Immunology; Stem cells

CXCL2